201 related articles for article (PubMed ID: 20636822)
1. Antibody-mediated modulation of immune responses.
Nimmerjahn F; Ravetch JV
Immunol Rev; 2010 Jul; 236():265-75. PubMed ID: 20636822
[TBL] [Abstract][Full Text] [Related]
2. FcγRIIB: a modulator of cell activation and humoral tolerance.
Lehmann B; Schwab I; Böhm S; Lux A; Biburger M; Nimmerjahn F
Expert Rev Clin Immunol; 2012 Mar; 8(3):243-54. PubMed ID: 22390489
[TBL] [Abstract][Full Text] [Related]
3. Fc-receptors as regulators of immunity.
Nimmerjahn F; Ravetch JV
Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
[TBL] [Abstract][Full Text] [Related]
4. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
[TBL] [Abstract][Full Text] [Related]
5. Stromal niches, plasma cell differentiation and survival.
Moser K; Tokoyoda K; Radbruch A; MacLennan I; Manz RA
Curr Opin Immunol; 2006 Jun; 18(3):265-70. PubMed ID: 16616478
[TBL] [Abstract][Full Text] [Related]
6. Killing some to make way for others.
Ravetch JV; Nussenzweig M
Nat Immunol; 2007 Apr; 8(4):337-9. PubMed ID: 17375094
[No Abstract] [Full Text] [Related]
7. Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Review article.
Jefferis R; Pound J; Lund J; Goodall M
Ann Biol Clin (Paris); 1994; 52(1):57-65. PubMed ID: 8210076
[TBL] [Abstract][Full Text] [Related]
8. [Role of the complement C3 protein in the control of the specific immune response].
Villiers CL; Villiers MB; Marche PN
Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
[TBL] [Abstract][Full Text] [Related]
9. Immunology. Tipping the scales toward more effective antibodies.
Woof JM
Science; 2005 Dec; 310(5753):1442-3. PubMed ID: 16322444
[No Abstract] [Full Text] [Related]
10. IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.
Mayumi M; Kuritani T; Kubagawa H; Cooper MD
J Immunol; 1983 Feb; 130(2):671-7. PubMed ID: 6217248
[TBL] [Abstract][Full Text] [Related]
11. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.
Szomolanyi-Tsuda E; Brien JD; Dorgan JE; Garcea RL; Woodland RT; Welsh RM
Virology; 2001 Feb; 280(2):160-8. PubMed ID: 11162830
[TBL] [Abstract][Full Text] [Related]
12. The scaffolding protein synapse-associated protein 97 is required for enhanced signaling through isotype-switched IgG memory B cell receptors.
Liu W; Chen E; Zhao XW; Wan ZP; Gao YR; Davey A; Huang E; Zhang L; Crocetti J; Sandoval G; Joyce MG; Miceli C; Lukszo J; Aravind L; Swat W; Brzostowski J; Pierce SK
Sci Signal; 2012 Jul; 5(235):ra54. PubMed ID: 22855505
[TBL] [Abstract][Full Text] [Related]
13. OxLDL-IgG immune complexes induce survival of human monocytes.
Oksjoki R; Kovanen PT; Lindstedt KA; Jansson B; Pentikäinen MO
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):576-83. PubMed ID: 16373614
[TBL] [Abstract][Full Text] [Related]
14. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
Peng KJ; Xiao LS; Fei Y; Wang SR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
[TBL] [Abstract][Full Text] [Related]
15. Targeting dendritic cells to enhance DNA vaccine potency.
You Z; Huang X; Hester J; Toh HC; Chen SY
Cancer Res; 2001 May; 61(9):3704-11. PubMed ID: 11325842
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
17. A role of FcgammaRIIB in the development of collagen-induced arthritis.
Nakamura A; Takai T
Biomed Pharmacother; 2004 Jun; 58(5):292-8. PubMed ID: 15194165
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Tervaert JW
Autoimmun Rev; 2009 Sep; 9(1):53-7. PubMed ID: 19285155
[TBL] [Abstract][Full Text] [Related]
20. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis.
Stevens RH; Benveniste E; Pineda E
J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
